Test Price
2,800 AED✅ Home Collection Available
CITED2 Gene Ventricular Septal Defect Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CITED2 للكشف عن عيب الحاجز البطيني من النوع الثاني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
يُقدم هذا الاختبار الجيني بتقنية التسلسل من الجيل التالي (NGS) كشفاً دقيقاً بنسبة 99.9% لجين CITED2 المرتبط بعيب الحاجز البطيني من النوع الثاني، مع خدمة سحب عينة منزلية معتمدة من الآيزو واستشارة هاتفية بعد النتيجة، تحت إشراف طبي متخصص.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Clinical Overview
This test employs Next‑Generation Sequencing (NGS) to interrogate the full coding region of the CITED2 gene, a key regulator in cardiac septation. It is intended for individuals with a suspected or family history of Ventricular Septal Defect Type 2 (VSD2), offering definitive molecular confirmation to guide cardiological and surgical management. Clinical report includes variant classification per ACMG 2026 guidelines and a customised genetic counselling summary.
| Feature | Our Test (ISO 9001:2015) | Closest Alternative (Standard Single‑Gene Sequencing) |
|---|---|---|
| Precision | >99.9% analytical sensitivity for SNVs, indels, and CNVs within CITED2 | 95‑97% sensitivity; may miss deep intronic or regulatory variants |
| Methodology | Next‑Generation Sequencing (Illumina platform, 150x mean coverage) with clinically validated bioinformatics pipeline, aligned to GRCh38 | Sanger sequencing of selected exons only |
| Turnaround Time | 3 to 4 Weeks | 6‑8 Weeks (often outsourced) |
Physician Insight & Safety Protocol
“A positive CITED2 variant must be interpreted within the complete echocardiographic and family context. This test does not replace a cardiologist’s clinical evaluation; it empowers you and your care team to make informed, life‑long decisions about surveillance and potential intervention.” — Dr. PRABHAKAR REDDY, DHA License 61713011
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
If you are on anticoagulants, anti‑arrhythmics, or any cardiac regimen, abrupt cessation can be life‑threatening. Always discuss test timing and medication adjustments with your treating cardiologist.
Exclusion Criteria & Emergency Red Flags
- Active febrile illness or acute cardiac decompensation (postpone collection).
- Known allergy to latex or antiseptic used in venipuncture (alternative materials available).
- ER Red Flags: If you experience chest pain, syncope, severe shortness of breath, or palpitations with dizziness, seek immediate emergency medical attention before scheduling this test.
Patient FAQ & Clinical Guidance / الأسئلة الشائعة
1. What is the purpose of this CITED2 genetic test?
Snippet: CITED2 gene testing by NGS detects pathogenic mutations causing Ventricular Septal Defect Type 2 accurately. This test analyses the CITED2 gene to identify variants that disrupt normal heart septum formation, providing a molecular diagnosis for patients with isolated or syndromic VSD2. It aids in personalised risk assessment, family screening, and informed reproductive counselling.
ملخص: يكشف اختبار جين CITED2 بتقنية التسلسل الجيني عن الطفرات المسببة لعيب الحاجز البطيني من النوع الثاني بدقة. يساعد التحليل في التشخيص الجزيئي وتقييم المخاطر العائلية والاستشارات الوراثية الدقيقة.
2. How is the sample collected and what is the turnaround time?
Snippet: A blood sample is collected via venipuncture; results are available within 3 to 4 weeks. You may provide whole blood, extracted DNA, or a single drop of blood on an FTA card—all options are accepted. Our cold‑chain home collection service ensures sample integrity from your doorstep to the ISO‑certified laboratory.
ملخص: تُسحب عينة دم وريدي بسيطة، وتصدر النتائج خلال 3 إلى 4 أسابيع. نقبل أيضاً الحمض النووي المستخلص أو بقعة دم على بطاقة FTA، مع خدمة سحب منزلي مبرّدة ومعتمدة.
3. Does insurance cover this test and what is the cost?
Snippet: The test costs 2800 AED, and we verify insurance coverage directly via WhatsApp before proceeding. Many UAE insurers include genetic testing for congenital heart defects under specialist referral. Our billing team will confirm eligibility and handle pre‑approval; simply send your insurance card and doctor’s request to +971 54 548 8731.
ملخص: تبلغ تكلفة الاختبار 2800 درهماً، ونتحقق من تغطية التأمين مباشرة عبر الواتساب قبل البدء. تشمل العديد من وثائق التأمين في الإمارات الفحوصات الجينية لعيوب القلب الخلقية بموجب إحالة طبية.
UAE Regulatory Compliance & Clinical Assurance
This is performed at a DHA‑licensed facility (License No. 9834453) and meets Federal Decree‑Law No. 41 of 2024, Art. 87 (genetic data protection). Minors require parental consent under UAE CDS Law 2026. Data privacy is governed by UAE PDPL and ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) standards. LOINC code: 81677-8 (CITED2 gene full mutation analysis). ICD‑10‑CM: Q21.0, Z15.09, Z82.79.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians